Endoscopy in Barrett's oesophagus: Adherence to standards and neoplasia detection in the community practice versus hospital setting

Journal of Internal Medicine

Volumn 264, Issue 4, 2008, Pages 370-378

  Pohl, H ^a,f   Aschenbeck, J ^e   Drossel, R ^e   Schroder A ^e   Mayr, M ^e   Koch, M ^a   Rothe, K ^a   Anders, M ^a   Voderholzer, W ^a   Hoffmann, J ^a   Schulz, H J ^b   Liehr, R M ^c   Gottschalk, U ^d   Wiedenmann, B ^a   Rosch T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Department of Gastroenterology

^c Humboldt Hospital

^d Maria Heimsuchung Hospital

^e Private Gastroenterology Office   (Germany)

^f DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Barrett's oesophagus; Oesophageal adenocarcinoma; Quality of endoscopy; Screening; Surveillance

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; FEMALE; GASTROINTESTINAL ENDOSCOPY; GERMANY; HEALTH CARE QUALITY; HEALTH CENTER; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADENOCARCINOMA; AGE FACTORS; AGED; BARRETT ESOPHAGUS; BERLIN; CARCINOMA IN SITU; COMMUNITY HEALTH SERVICES; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HOSPITALS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PRECANCEROUS CONDITIONS; RETROSPECTIVE STUDIES;

EID: 51649111388     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.01977.x     Document Type: Article

References (42)

1. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998 83:2049 53.
2. El-Serag HB, Mason AC, Petersen N, Key CR. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002 50:368 72.
3. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005 97:142 6.
4. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000 119:333 8.
5. Caygill CP, Watson A, Reed PI, Hill MJ. Characteristics and regional variations of patients with Barrett's oesophagus in the UK. Eur J Gastroenterol Hepatol 2003 15:1217 22.
6. Gopal DV, Lieberman DA, Magaret N et al. Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium. Dig Dis Sci 2003 48:1537 41.
7. Falk GW, Thota PN, Richter JE, Connor JT, Wachsberger DM. Barrett's esophagus in women: demographic features and progression to high-grade dysplasia and cancer 1422. Clin Gastroenterol Hepatol 2005 3:1089 94.
8. Ford AC, Forman D, Reynolds PD, Cooper BT, Moayyedi P. Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus. Am J Epidemiol 2005 162:454 60.
9. Guardino JM, Khandwala F, Lopez R, Wachsberger DM, Richter JE, Falk GW. Barrett's esophagus at a tertiary care center: association of age on incidence and prevalence of dysplasia and adenocarcinoma. Am J Gastroenterol 2006 101:2187 93.
10. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006 4:566 72.
11. Aldulaimi DM, Cox M, Nwokolo CU, Loft DE. Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival. Eur J Gastroenterol Hepatol 2005 17:943 50.
12. Inadomi JM, Sampliner R, Lagergren J, Lieberman D, Fendrick AM, Vakil N. Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis 5. Ann Intern Med 2003 138:176 86.
13. Provenzale D, Schmitt C, Wong JB. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol 1999 94:2043 53.
14. Sharma P, McQuaid K, Dent J et al. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004 127:310 30.
15. Hirota WK, Zuckerman MJ, Adler DG et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 2006 63:570 80.
16. Reid BJ, Weinstein WM, Lewin KJ et al. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988 94:81 90.
17. Playford RJ. New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut 2006 55:442.
18. Koop H, Schepp W, Muller-Lissner S et al. Consensus conference of the DGVS on gastroesophageal reflux. Z Gastroenterol 2005 43:163 4.
19. Neil-Covin L, Casson AG, Malatjalian D, Veldhuyzen van ZS. A survey of Canadian gastroenterologists about the management of Barrett's esophagus. Can J Gastroenterol 2003 17:313 7.
20. Cruz-Correa M, Gross CP, Canto MI et al. The impact of practice guidelines in the management of Barrett esophagus: a national prospective cohort study of physicians. Arch Intern Med 2001 161:2588 95.
21. Moss A, Clarke E, Crowe J, Lennon J, Mac MP. Management of Barrett's oesophagus in 2001 in Ireland. Ir J Med Sci 2003 172:174 6.
22. Falk GW, Ours TM, Richter JE. Practice patterns for surveillance of Barrett's esophagus in the united states. Gastrointest Endosc 2000 52:197 203.
23. Bampton PA, Schloithe A, Bull J, Fraser RJ, Padbury RT, Watson DI. Improving surveillance for Barrett's oesophagus. BMJ 2006 332:1320 3.
24. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002 97:1888 95.
25. Cohen J, Safdi MA, Deal SE et al. Quality indicators for esophagogastroduodenoscopy. Gastrointest Endosc 2006 4 (Suppl. S10 5.
26. Barclay RL, Vicari JJ, Doughty AS, Johanson JF, Greenlaw RL. Colonoscopic withdrawal times and adenoma detection during screening colonoscopy. N Engl J Med 2006 355:2533 41.
27. Vieth M. Low-grade dysplasia in Barrett's esophagus-an innocent bystander? Contra. Endoscopy 2007 39:647 9.
28. Wani S, Choi W, Sharma P. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Pro. Endoscopy 2007 39:643 6.
29. Pech O, Vieth M, Schmitz D et al. Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia in Barrett's oesophagus. Scand J Gastroenterol 2007 42:682 8.
30. Data confirmed by the Regional Health Authority (Berliner Senat für Gesundheit). 2007.
31. Data from 'Kassenaerztliche Vereinigung Berlin' (practitioners reimbursement organization Berlin, Germany). 2007.
32. Grol R, Dalhuijsen J, Thomas S, Veld C, Rutten G, Mokkink H. Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. BMJ 1998 317:858 61.
33. Polymeros D, Triantafyllou K, Tzathas C, Emmanuel T, Tsironi E, Ladas SD. Accuracy of measurements of the length of esophageal lesions: an experimental study. Endoscopy 2007 39:948 51.
34. Egger K, Meining A, Werner M, Hofler H, Classen M, Rosch T. Endoscopic measurement of Barrett's esophagus length is unreliable - a prospective comparative biopsy study. Z Gastroenterol 2004 42:499 504.
35. Trudgill NJ, Suvarna SK, Kapur KC, Riley SA. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut 1997 41:585 9.
36. Meining A, Ott R, Becker I et al. The Munich Barrett follow up study: suspicion of Barrett's oesophagus based on either endoscopy or histology only - what is the clinical significance? Gut 2004 53:1402 7.
37. Padda S, Ramirez FC. Accuracy in the diagnosis of short-segment Barrett's esophagus: the role of endoscopic experience. Gastrointest Endosc 2001 54:605 8.
38. Johnston MH, Hammond AS, Laskin W, Jones DM. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy. Am J Gastroenterol 1996 91:1507 11.
39. Mandal A, Playford RJ, Wicks AC. Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK. Aliment Pharmacol Ther 2003 17:1319 24.
40. van Sandick JW, Bartelsman JF, van Lanschot JJ, Tytgat GN, Obertop H. Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines. Eur J Gastroenterol Hepatol 2000 12:111 7.
41. Schnell TG, Sontag SJ, Chejfec G et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001 120:1607 19.
42. Bytzer P, Christensen PB, Damkier P, Vinding K, Seersholm N. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol 1999 94:86 91.